MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

被引:12
作者
Olarte, Irma [1 ]
Martinez, Adolfo [1 ]
Ramos-Penafiel, Christian [1 ]
Castellanos-Sinco, Humberto [1 ]
Zamora, Jorge [1 ]
Collazo-Jaloma, Juan [1 ]
Gutierrez, Mario [1 ]
Gutierrez-Kobeh, Laila [2 ]
Chavez-Olmos, Pedro [3 ]
Manzanilla, Hugo [4 ]
Garrido-Guerrero, Efrain [3 ]
Ordonez-Razo, Rosa M. [5 ]
Miranda, Enrique I. [1 ,6 ]
机构
[1] Hosp Gen Mexico City, Serv Hematol, Lab Biol Mol, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico
[3] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico
[4] Hosp Gen Mexico City, Serv Urol, Mexico City 06726, DF, Mexico
[5] IMSS, Ctr Med Siglo 21, Hosp Pediat, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico
[6] Westhill Univ, Sch Med, Mexico City, DF, Mexico
关键词
MAGE-A3; Expression; Prognostic; DLBCL; Lymphoma; NON-HODGKINS-LYMPHOMA; TISSUE MICROARRAY; GENE-EXPRESSION; CANCER; CHEMOTHERAPY; PREDICTION; CARCINOMA; SURVIVAL; MYELOMA; ANTIGEN;
D O I
10.1179/102453311X13085644680384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study evaluates the prognostic value of MAGE-A3 expression in 28 diffuse large B-cell lymphoma (DLBCL) patients. A significant association was observed between MAGE-A3 expressions, assessed by quantitative real-time RT-polymerase chain reaction (PCR), with advanced stages of disease (P<0.05). Elevated serum lactate dehydrogenase (LDH) levels and International Prognostic Index (IPI) score were significantly higher in MAGE-A3-positive patients (P=0.025 and P=0.004, respectively). Expression of MAGE-A3 was associated with poor response to treatment and a significantly shorter overall survival (P<0.001). Our data address new information in the association of MAGE-A3 expression and poor prognosis in DLBCL patients.
引用
收藏
页码:368 / 372
页数:5
相关论文
共 31 条
[1]   Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma [J].
Ait-Tahar, Kamel ;
Liggins, Amanda P. ;
Collins, Graham P. ;
Campbell, Andrew ;
Barnardo, Martin ;
Lawrie, Charles ;
Moir, Donald ;
Hatton, Chris ;
Banham, Alison H. ;
Pulford, Karen .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (04) :396-407
[2]   EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA [J].
BRASSEUR, F ;
RIMOLDI, D ;
LIENARD, D ;
LETHE, B ;
CARREL, S ;
ARIENTI, F ;
SUTER, L ;
VANWIJCK, R ;
BOURLOND, A ;
HUMBLET, Y ;
VACCA, A ;
CONESE, M ;
LAHAYE, T ;
DEGIOVANNI, G ;
DERAEMAECKER, R ;
BEAUDUIN, M ;
SASTRE, X ;
SALAMON, E ;
DRENO, B ;
JAGER, E ;
KNUTH, A ;
CHEVREAU, C ;
SUCIU, S ;
LACHAPELLE, JM ;
POUILLART, P ;
PARMIANI, G ;
LEJEUNE, F ;
CEROTTINI, JC ;
BOON, T ;
MARCHAND, M .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :375-380
[3]   Diffuse large cell lymphoma [J].
Coiffier, B .
CURRENT OPINION IN ONCOLOGY, 2001, 13 (05) :325-334
[4]   Cancer/testis genes in multiple myeloma:: Expression patterns and prognosis value determined by microarray analysis [J].
Condomines, Maud ;
Hose, Dirk ;
Raynaud, Pierre ;
Hundemer, Michael ;
De Vos, John ;
Baudard, Marion ;
Moehler, Thomas ;
Pantesco, Veronique ;
Moos, Marion ;
Schved, Jean-Francois ;
Rossi, Jean-Francois ;
Reme, Thierry ;
Goldschmidt, Hartmut ;
Klein, Bernard .
JOURNAL OF IMMUNOLOGY, 2007, 178 (05) :3307-3315
[5]   Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab [J].
Czuczman, M. S. ;
Grillo-Lopez, A. J. ;
Alkuzweny, B. ;
Weaver, R. ;
Larocca, A. ;
McLaughlin, P. .
LEUKEMIA & LYMPHOMA, 2006, 47 (09) :1830-1840
[6]  
Dhodapkar Madhav V, 2003, Cancer Immun, V3, P9
[7]  
Fisher Richard I, 2004, Hematology Am Soc Hematol Educ Program, P221
[8]   Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood [J].
Han, Mi Hwa ;
Eom, Hyeon-Seok ;
Park, Weon-Seo ;
Yun, Tak ;
Park, Sohee ;
Kim, Hyun-Ju ;
Jeon, Chang-Ho ;
Kong, Sun-Young .
LEUKEMIA RESEARCH, 2010, 34 (09) :1127-1131
[9]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481